Experimental CAR t therapy takes on solid tumors in first human trial
Disease control
Recruiting now
This early-phase trial is testing a new immunotherapy called LEU011 for people with advanced solid tumors that have not responded to other treatments. LEU011 uses the patient's own immune cells, modified to better recognize and attack tumor cells. The study aims to find a safe do…
Phase: PHASE1, PHASE2 • Sponsor: Leucid Bio • Aim: Disease control
Last updated Jun 26, 2026 13:13 UTC